Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 May;34(4):417-21.
doi: 10.1023/b:neab.0000018755.99063.05.

Stimulation of the immune response during activation of the dopaminergic system in mice with opposite types of behavior

Affiliations
Comparative Study

Stimulation of the immune response during activation of the dopaminergic system in mice with opposite types of behavior

G V Idova et al. Neurosci Behav Physiol. 2004 May.

Abstract

Studies reported here demonstrated that activation of the dopaminergic system induces increases in the immune response regardless of the type of behavior in mice (line CBA), i.e., in aggressive mice, submissive mice, and mice lacking experience of victory or defeat (controls). Changes in the activity of the dopaminergic system were induced with SKF-38393, a selective agonist of dopamine D1 receptors, and with p-chlorophenylalanine (PCPA), which we have previously shown to activate D2 receptors. In the aggressive form of behavior, which was characterized by strong (compared with controls) immune responses, SKF-38393 and PCPA led to further increases in the immune response. In submissive mice, activation of the dopaminergic system altered the nature of the immune response, with immunostimulation, as in aggression. It is suggested that activation of the dopaminergic system in conditions of defined psychoemotional status fixed by acquisition of opposite types of behavior, induces the formation of a new neurochemical pattern--the dopaminergic set--which led to changes in the nature and intensity of the immune response.

PubMed Disclaimer

References

    1. Physiol Behav. 1998 Jun 1;64(3):353-60 - PubMed
    1. Nature. 1965 Sep 4;207(5001):1106-7 - PubMed
    1. Neurosci Behav Physiol. 1992 Sep-Oct;22(5):364-9 - PubMed
    1. Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):535-40 - PubMed
    1. Physiol Behav. 2001 Jun;73(3):385-91 - PubMed

Publication types

LinkOut - more resources